# Effect of Adding Dexmedetomidine As Adjuvant to Bupivacaine in US Guided ESPB for Post MRM Pain Management

> **NCT06022614** · NA · COMPLETED · sponsor: **Abanoub Habib** · enrollment: 60 (actual)

## Conditions studied

- Erector Spinae Plane Block

## Interventions

- **DRUG:** Use Bupivacaine 0.25% Injectable Solution
- **DRUG:** Bupivacaine 0.25% Injectable Solution plus Dexmedetomidine

## Key facts

- **NCT ID:** NCT06022614
- **Lead sponsor:** Abanoub Habib
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-15
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06022614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06022614, "Effect of Adding Dexmedetomidine As Adjuvant to Bupivacaine in US Guided ESPB for Post MRM Pain Management". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06022614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*